Conferences raise new questions about HAART use by women.
Hanna
L
L
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D018450:Disease Progression; D004352:Drug Resistance, Microbial; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006297:Health Services Accessibility; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012307:Risk Factors; D019562:Viral Load; D016387:Women's Health
D019380:Anti-HIV Agents